TARSUS PHARMACEUTICALS, INC. (TARS) Net margin 2021–2025
TARSUS PHARMACEUTICALS, INC. (TARS) net profit margin by fiscal year — reported net income divided by reported revenue.
-14.7%FY2025 · since FY2021: -24.2% → -14.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -14.7% | +48.4 pp |
| FY2024 | -63.2% | +715.7 pp |
| FY2023 | -778.9% | -538.4 pp |
| FY2022 | -240.5% | -216.3 pp |
| FY2021 | -24.2% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More TARS financial trends
TARS RevenueTARS Net incomeTARS Gross profitTARS Gross marginTARS Operating incomeTARS Operating marginTARS Operating cash flowTARS Free cash flowTARS Capital expendituresTARS Return on equityTARS Stock buybacksTARS Dividends paidTARS Total assetsTARS Total liabilitiesTARS Shareholders’ equityTARS overview →